APP and Alzheimer disease: Deficits in mitochondrial morphology or dynamics have been observed in fibroblasts from sporadic AD patients [170,171,172,173,174], in mice overexpressing APP [170,175], or even in experimental AD models linked to Aβ peptide treatments.